Kiora Pharmaceuticals Statistics Share Statistics Kiora Pharmaceuticals has 3.04M
shares outstanding. The number of shares has increased by 2.47%
in one year.
Shares Outstanding 3.04M Shares Change (YoY) 2.47% Shares Change (QoQ) 1.44% Owned by Institutions (%) 1.12% Shares Floating 2.82M Failed to Deliver (FTD) Shares 22,697 FTD / Avg. Volume 4.87%
Short Selling Information The latest short interest is 51.77K, so 1.7% of the outstanding
shares have been sold short.
Short Interest 51.77K Short % of Shares Out 1.7% Short % of Float 1.76% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 3.56 and the forward
PE ratio is -0.99.
Kiora Pharmaceuticals's PEG ratio is
-0.03.
PE Ratio 3.56 Forward PE -0.99 PS Ratio 0.8 Forward PS 9.9 PB Ratio 0.5 P/FCF Ratio 1.49 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation Kiora Pharmaceuticals has an Enterprise Value (EV) of 9.04M.
EV / Sales 0.56 EV / EBITDA 1.57 EV / EBIT 1.06 EV / FCF 1.06
Financial Position The company has a current ratio of 4.94,
with a Debt / Equity ratio of 0.
Current Ratio 4.94 Quick Ratio 4.94 Debt / Equity 0 Debt / EBITDA 0.01 Debt / FCF 0.01 Interest Coverage 210.31
Financial Efficiency Return on Equity is 13.95% and Return on Invested Capital is 9.39%.
Return on Equity 13.95% Return on Assets 9.85% Return on Invested Capital 9.39% Revenue Per Employee $1.33M Profits Per Employee $299.56K Employee Count 12 Asset Turnover 0.44 Inventory Turnover n/a
Taxes Income Tax 2.07M Effective Tax Rate 36.49%
Stock Price Statistics The stock price has increased by -24.69% in the
last 52 weeks. The beta is -0.64, so Kiora Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.64 52-Week Price Change -24.69% 50-Day Moving Average 2.96 200-Day Moving Average 3.25 Relative Strength Index (RSI) 25.07 Average Volume (20 Days) 465,822
Income Statement In the last 12 months, Kiora Pharmaceuticals had revenue of 16.02M
and earned 3.59M
in profits. Earnings per share was 0.93.
Revenue 16.02M Gross Profit 16M Operating Income 4.51M Net Income 3.59M EBITDA 5.75M EBIT 5.68M Earnings Per Share (EPS) 0.93
Full Income Statement Balance Sheet The company has 3.79M in cash and 57.17K in
debt, giving a net cash position of 3.74M.
Cash & Cash Equivalents 3.79M Total Debt 57.17K Net Cash 3.74M Retained Earnings -143.38M Total Assets 34.02M Working Capital 21.83M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 8.56M
and capital expenditures -6.26K, giving a free cash flow of 8.55M.
Operating Cash Flow 8.56M Capital Expenditures -6.26K Free Cash Flow 8.55M FCF Per Share 2.21
Full Cash Flow Statement Margins Gross margin is 99.88%, with operating and profit margins of 28.15% and 22.44%.
Gross Margin 99.88% Operating Margin 28.15% Pretax Margin 35.33% Profit Margin 22.44% EBITDA Margin 35.87% EBIT Margin 28.15% FCF Margin 53.39%
Dividends & Yields KPRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 28.13% FCF Yield 66.93%
Dividend Details Analyst Forecast The average price target for KPRX is $10,
which is 309.8% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 309.8% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 11.79 Graham Upside 383.2%
Stock Splits The last stock split was on Jun 11, 2024. It was a
backward
split with a ratio of 1:9.
Last Split Date Jun 11, 2024 Split Type backward Split Ratio 1:9
Scores Altman Z-Score -5.76 Piotroski F-Score 2
